Skip to main content
Download PDF

Prevalence, risk factors, and medical costs of Chlamydia trachomatis infections in Shandong Province, China: a population-based, cross-sectional study

BMC Infectious Diseases volume 18, Article number: 534 (2018) Cite this article

Abstract

Background

A population-based study of Chlamydia trachomatis (CT) infections is essential in designing a specific control program; however, no large investigation of CT infections among the general population in mainland China has been conducted since 2000. We aimed to determine the prevalence, risk factors, and associated medical costs of CT among residents, 18–49 years of age, in Shandong, China.

Methods

From May to August 2016, a multistage probability sampling survey involving 8074 individuals was distributed. Data were collected via face-to-face interviews, followed by self-administered questionnaire surveys. First-void urines were collected and tested for CT and Neisseria gonorrhoeae (NG) using nucleic acid amplification.

Results

The weighted prevalence of CT infection was 2.3% (95% confidence interval [CI], 1.5–3.2) in females and 2.7% (1.6–3.8) in males. Women, 30–34 years of age, had the highest prevalence of CT infections (3.5%, 2.6–4.4), while the highest prevalence of CT infections in males was in those 18–24 years of age (4.3%, 0.0–8.8). Neisseria gonorrhoeae infection had a prevalence of 0.1% (0.0–0.3) in women and 0.03% (0.0–0.1) in men. Risk factors for CT infections among females included being unmarried, divorced, or widowed (odds ratio [OR], 95% CI 3.57, 1.54–8.24) and having two or more lifetime sex partners (3.72, 1.14–12.16). Among males, first intercourse before 20 years of age (1.83, 1.10–3.02) and having two or more lifetime sex partners (1.85, 1.14–3.02) were associated with CT infections. The estimated lifetime cost of CT infections in patients 18–49 years of age in Shandong was 273 million (range, 172–374 million) China Renminbi in 2016.

Conclusions

This study demonstrated a high burden of CT infections among females < 35 years of age and males < 25 years of age in Shandong. Thus, a CT infection control program should focus on this population, as well as others with identified risk factors.

Peer Review reports

Background

Chlamydia trachomatis (CT) is the most commonly diagnosed bacterial sexually transmitted infection (STI) worldwide [1]. According to the 2015 global STI surveillance report from the World Health Organization (WHO), global estimates of new CT infections in 2012 were approximately 131 million [2]. Legally notifiable STIs, such as syphilis and HIV, have increased significantly in China from 2004 to 2013, with annual percentage changes of 16.3% for both STIs [3]; however, little information is available regarding the incidence or prevalence of CT infections among the general population in mainland China over the past decade. The current estimated burden of CT infections in China is based primarily on national or regional STIs surveillance sites; however, surveillance data does not measure the true burden of CT infections among the general population because infections are often asymptomatic and undiagnosed. Furthermore, the reported data are frequently misclassified or duplicated [4, 5]. A population-based survey of STIs provided an estimate of the prevalence, determinants, and economic burden of CT infections, which facilitate the design and delivery of a CT infection control program [4]. Because the first national population-based CT infection investigation conducted in China was in 1999–2000, more than 18 years ago, the information for CT infection control and prevention strategies is outdated [6]. Another population-based CT infection survey was conducted in Shanxi Province of China in 2004, but the sample size was small (n = 399) [7]. Therefore, a population-based CT infection study with a large sample size is needed in China.

The Chinese government replaced the one-child policy with a universal two-child policy in October 2015, implying that more couples have opportunity to have their second child [8]. Thus, more CT infections involving couples may suffer from infertility and adverse pregnancy outcomes, such as ectopic pregnancy, without early screening [9]. The complication burden due to CT infection may be higher after the introduction of the universal two-child policy. Furthermore, CT infections and other STIs could facilitate transmission of HIV [10]. Fortunately, most of the bacterial STIs, including CT infections are treatable, so screening among high-risk populations enables early identification and treatment, which reduce the disease burden and adverse outcomes [11].

A number of population-based studies of CT infections have been conducted, including the United States and European and Oceania countries [4, 5, 12, 13]. Several strategies to improve sexual health have been implemented in a number of developed countries or regions based on findings from these population-based studies [14, 15]. Thus, it is essential to conduct a population-based CT infection investigation and provide official recommendations for CT infection-specific control interventions in China.

Shandong Province is a coastal province located in eastern China, with a population of 98.5 million in 2015, accounting for 7% of the total population in China. This study was a population-based, cross-sectional study conducted from 9 May to 25 August 2016 in Shandong Province. We undertook this study to determine the prevalence, risk factors, and associated medical costs of CT infections among the general population 18–49 years of age in China.

Methods

Study design and participants

The population was sampled to represent the general population of Shandong Province, China (18–49 years of age). General population refers to males and females who had lived in their current residence for at least the past 6 months. The estimated sample size was 8074 individuals based on the national survey conducted in 1999–2000 [6]. (Additional file 1) The multi-stage sampling process included four steps, as follows: Shandong Province was divided into four strata based on geographic region (east, northwest, south, and middle); 2–4 urban districts or counties were randomly extracted from each stratum, producing 12 primary sampling units (PSUs; Fig. 1); 4–7 subunits (rural townships and urban street districts) were selected from each PSU using the probability proportionate to size sampling (PPS) method; a total of 59 subunits were selected; 3–12 rural villages or urban communities were selected from each subunit using the aforementioned sampling method, with more populated subunits having a higher probability of selection; villages and communities were selected with a proportion of 1:1; a total of 184 rural villages and 183 urban communities were included; residents, 18–49 years of age, who had lived in their current residence for at least the past 6 months were selected and arrayed in order by age and gender; systematic sampling was performed based on the gender and age distribution of the Shandong Province population to produce the sample; Thus, 22 persons were drawn from each village or community according to sample size and number of selected villages or communities.

Fig. 1
figure1

Geographic locations of Shandong Province and 12 primary sampling units

Full size image

The inclusion criteria were as follows: participants born between 1 January 1966 and 31 September 1997; continuous residence at the study site for at least the past 6 months; consent to provide urine specimens for testing; and willing to participate in the study and complete the questionnaires. The exclusion criteria were as follows: individuals denying sexual debut (including oral sex); and inability to provide correct information, such as individuals with a mental illness or alcohol abusers.

This study was approved by the Ethics Committee of Shandong Provincial Institute of Dermatology and Venereology (approval number: 2016–04). Oral informed consent was obtained from each participant by interviewers before interview.

Procedures

Before implementation of this survey, 3 days of training on fieldwork staff was provided by epidemiology and clinical laboratory professionals in each of the PSUs. One laboratory technician for urine collection and coding, one male and one female questionnaire interviewers, and one financial staff for providing rewards to participants were selected on the basis of course performance for each field team. A trained supervisor from the study group was also assigned to each field team for ethics and quality control of the interview.

Before sampling, individuals who continuously lived in their current residences for at least the past 6 months were identified by village/community committee staff or physicians by 3 steps. First, they referred to the official registers of household or health record of local residents for eligible individuals. Second, they inquired and recorded unregistered migrants who had lived in the local village/community for 6 months or more. Third, these two groups of people were combined in a roster for sampling. The sampled participants were informed to be interviewed in the village/community clinic or meeting room in private. For individuals who could not be reached via telephone, staff or physicians would visit them in their home. Individuals who could not be reached after repeated visits were excluded from the study. To retain privacy, questionnaire interviews were performed in a private room, and interviewers were the same gender as the respondent. Most of the selected respondents worked during the daytime, so the interviews were usually performed early in the morning or in the evening. Computer-based interviews were not performed because the pilot investigation showed that many participants could not use the computer to navigate the questionnaire, especially in villages. We adopted questionnaire-based interviews to collect information. Face-to-face interviews addressed demographic information, including gender, age, marital status (unmarried, married, divorced, or widowed), educational level (elementary school or below, middle school, senior high school or technical school, and university or above), and location of residence (rural or urban). Other information on the questionnaires was completed by the respondents themselves. The structured questionnaires included information regarding occupation, income, living status (living with family, living with roommates, or living alone), living with a spouse (yes or no), smoking (a smoker was defined as someone who had smoked > 100 cigarettes during their lifetime), number of episodes of intoxication in the past year (0, 1–3, 4–6, and > 6), STIs (including syphilis, gonorrhea, CT infection, condyloma acuminatum, genital herpes, and HIV infection) in the past 5 years (yes or no), quality of sex life (satisfied or not satisfied), sexual behaviors, such as age at first intercourse (≤20 years and > 20 years), number of sex partners (1 and ≥ 2), and number of new sex partners in the past year (≤ 1 and ≥ 2). After the interview, the supervisor checked the questionnaires for missing values and logical errors and wrote a unique alphanumeric code on the questionnaires instead of the individual’s name.

Every respondent was instructed not to urinate for at least 1 h before they participated in the interview. Approximately 30–50 ml of first-void urine was collected into a urine cup. Laboratory technicians promptly transferred the urine into Cobas PCR Media tubes (Roche Molecular Systems, Inc., Branchburg, New Jersey, USA) using a disposable pipette and the tube was inverted 5 times to mix. Each specimen was labeled with a unique alphanumeric code, which was the same as on the questionnaire. Urine was transported inside a Styrofoam cooler to the local laboratory within 3 h of collection and was stored 4 °C as soon as the staff received the specimen. Urine was transported inside the cooler to the laboratory of Shandong Provincial Institute of Dermatology and Venereology in Jinan within 2 weeks.

Chlamydia trachomatis and Neisseria gonorrhoeae (NG) DNA in urine specimens were detected with a Roche Cobas 4800 CT/NG Assay (Roche Molecular Systems, Inc.), which had a sensitivity of 96.6% and a specificity of 100% [16]. Only participants with positive results were notified, then referred to a local STI clinic or general hospital for treatment.

Statistical analysis

Questionnaire information, as well as testing results, was double-entered into Epidata 3.1 (EpiData association, Odense, Denmark); discrepancies were checked against raw data. We applied selection probability weights which were inversely proportional to the selection probabilities for the number of units at each sampling step to balance differences in the probabilities of selection. Non-response weighting was made by adjustment among those who participated in this survey with those who did not. Post-stratification weighting was made by adjusting data according to age and gender distribution of the Shandong census data. We analyzed data with surveyfreq and surveylogistic methods using SAS 9.3 (SAS Institute, Inc., Cary, NC, USA). The prevalence with 95% confidence interval (CI) of CT and NG was calculated based on total population weights and Taylor series linearization. We determined the association between CT infection and demographic and behavioral variables with logistic regression and reported crude odds ratio (ORs) in univariate analysis. Risk factors with a p value < 0.20 in univariate analysis were applied into the multivariate logistic model. Adjusted ORs and 95% CIs are presented. The variance inflation factor (VIF), condition index, and variance proportions were calculated to examine multicollinearity among risk factors. Maximal variance inflation factor values ≥10 or maximal condition index values ≥10 and a corresponding variance proportion value > 0.5 indicated multicollinearity among variables. All tests were two-sided, and a p value < 0.05 was considered statistically significant.

Proportion of symptomatic and treatment, incidences of various complications after CT infection were on the basis of our primary data as well as previous published studies [17, 18] (Figs. 2 and 3, Additional file 2). Medical costs for CT infections were based on diagnosis and treatment of the infection and complications; costs related to transportation, lodging, and time missed from work were not included into analysis. According to guidelines for STI treatment and control in China, we assumed that the diagnosis of CT infections was established with PCR testing and the treatment of CT infections involved a single 1 g dose of oral azithromycin [19]. Medical costs of cases with complications were estimated based on published research in Shandong Province [17]. The discounted rate of medical costs was assumed to be 3%. Sensitivity analysis was performed by adding uncertainty factors, such as the prevalence of CT infections, proportion of asymptomatic CT infections [20], and diagnostic method (antigen detection), into the computation.

Fig. 2
figure2

The method of calculating the medical costs of CT infection for females. Abbreviations: PID pelvic inflammatory disease, CT Chlamydia trachomatis

Full size image
Fig. 3
figure3

The method of calculating the medical costs of CT infection for males. Abbreviations: CT Chlamydia trachomatis

Full size image

Results

Of the 8074 individuals originally sampled, 184 could not be reached via telephone and were not at home on repeated visits. Among the 7890 individuals who were contacted, 231 declined to participate in this survey, 391 denied a sexual debut, and 5 had mental illnesses, leaving 7263 (90.0%) individuals who participated in the study and provided a urine sample. In addition, 60 urine samples were excluded due to mislabeling or insufficient urine, leaving 7203 (89.2%) satisfactory urine sample with test results for analysis (Fig. 4).

Fig. 4
figure4

Flow chart for participant selection. Abbreviations: CT Chlamydia trachomatis, NG neisseria gonorrhoeae

Full size image

Prevalence of CT and NG infections

The weighted age-specific prevalence of CT and NG infections is shown in Table 1. Of the 7203 urine samples tested, 167 participants (90 females and 77 males) tested positive for CT. The estimated prevalence of CT in the general population, 18–49 years of age, in 2016 was 2.3% (95% CI, 1.5–3.2) for females and 2.7% (95% CI, 1.6–3.8) for males, corresponding to approximately 1,263,000 infections (95% CI, 774,000-1,753,000) in Shandong. No significant difference in the prevalence of CT infections existed between females and males (p = 0.52). The highest prevalence of CT infections occurred in females 30–34 years of age (3.5%; 95% CI, 2.6–4.4), followed by females 18–24 (3.2%; 95% CI, 0.4–6.1) and 25–29 years of age (2.9%; 95% CI, 1.9–3.8). The prevalence of CT infections in females 18–34 years of age (3.2%; 95% CI, 1.8–4.6) was significantly higher than females 35–49 years of age (1.5%; 95% CI, 0.8–2.2 [OR, 2.16; 95% CI, 1.14–4.08]); however, the highest prevalence of CT infections occurred in males 18–24 years of age (4.3%; 95% CI, 0.0–8.8). For females, the highest prevalence was in those from South region (3.0%, 95%CI, 2.2–3.9) of Shandong. By contrast, for males, the highest prevalence was in those from Northwest (3.0%, 95%CI, 0.0–7.7) and Middle region (3.0%, 95%CI, 1.1–4.9) of Shandong. The prevalence of CT infections for urban and rural residents was 2.8% (95% CI, 1.5–4.0) and 2.2% (95% CI, 1.4–2.9), respectively, but the difference was not statistically significant (p = 0.42).

Table 1 The weighted prevalence of CT and NG in participants 18–49 years of age in Shandong, China
Full size table

Of the 7203 urine samples tested, 6 participants (5 females and 1 male) tested positive for gonorrhoea. The estimated prevalence of gonorrhoea in the target population in 2016 was 0.1% (95% CI, 0.0–0.3) for females and 0.03% (95% CI, 0.0–0.1) for males, but the difference was not significant between female and male residents (p = 0.25). The estimated number of NG infections in Shandong corresponded to approximately 35,000 cases (95% CI, 0–83,000). The prevalence of NG infections among urban residents (0.10%; 95% CI, 0.0–0.2) was significantly higher than rural residents (0.03%; 95% CI, 0.0–0.1 [OR, 3.58; 95% CI, 1.08–11.83]). Because of the limited number of NG-positive cases, the following analysis focused on CT infections.

Risk factors for CT infections

Based on univariate analyses, risk variables associated with CT infections for both males and females 18–49 years of age included being unmarried/divorced/widowed, first sexual intercourse before 20 years of age, and having ≥2 sex partners. For females, an increased prevalence of CT infections was also associated with a higher level of education. For males, an increased prevalence of CT infections was associated with living alone, living separated from their spouse, and having been infected with a STI in the past 5 years, while a decreased prevalence of CT infections was associated with increasing age (Table 2).

Table 2 Risk factors for CT in urine specimens from participants 18–49 years of age in Shandong, China
Full size table

In the multivariate logistic model, factors remaining significantly associated with CT infection for women were being unmarried/divorced/widowed (OR, 3.57; 95% CI, 1.54–8.24) and having ≥2 sex partners (OR, 3.72; 95% CI, 1.14–12.16). A higher level of education was marginally associated with CT infections in females. In males, first sexual intercourse before 20 years of age (OR, 1.83; 95% CI, 1.10–3.02) and having ≥2 sex partners (OR, 1.85; 95% CI, 1.14–3.02) remained significantly associated with CT infections (Table 2).

In the collinearity diagnosis, the maximal VIF was 1.17 and the maximal condition index was 1.55 for the female regression model, while the maximal VIF was 1.29 and the maximal condition index was 1.87 for the male regression model, which indicated no multicollinearity in the multivariate logistic analysis.

Medical costs for CT infections

Based on calculated costs for treatment of CT complications in 2016 (Additional file 2), we estimated that the lifetime total costs for CT infections for patients 18–49 years of age in Shandong Province was 273 million Renminbi (RMB), which corresponds to 348 RMB for each CT infection in females and 102 RMB for each CT infection in males.

In sensitivity analysis, the estimated range for the total lifetime costs of CT infections in patients 18–49 years of age in Shandong was 172–374 million RMB in 2016. The estimated range of medical costs for each female and male patient was 339–361 RMB and 97–108 RMB, respectively. (Additional file 2).

Discussion

This is the first representative population-based cross-sectional study with a large sample size to determine the epidemiology of CT infections in mainland China since 1999–2000. In addition, the medical costs of CT infections and associated complications were estimated for the first time in China. Compared with the only national population-based STI prevalence study conducted in China (1999–2000), which reported a CT prevalence of 0.6% for females and 1.1% for males 20–24 years of age in China, the results from this study showed that the prevalence of CT infections has now increased 5-fold for females and 3-fold for males in this age group [6]. This change appears to be influenced by increased premarital and extramarital sexual activity in China, especially among youth [21]. According to a study conducted in 1999, approximately 15% of male and 9% of female university students had participated in premarital sexual activity [22]; however, another study concluded that 26% of college students had sexual intercourse in 2010 [21]. The rate of premarital sexual activity was even higher among out of school/community young adults than among those in school [23].

We compared our study with other population-based cross-sectional surveys that have used a complex sampling design and urine tests of infection. In 2014–2016, Wong WC et al. performed a survey of 733 sexually experienced individuals in Hong Kong, China [24]. Among females 18–49 years of age, prevalence of CT infections was 2.0% (95% CI, 1.0–3.7) in Hong Kong compared with 2.3% (95% CI, 1.5–3.2) in Shandong Province. Among males 18–49 years of age, the prevalence was 1.5% (95% CI, 0.6–3.6) in Hong Kong compared with 2.7% (95% CI, 1.6–3.8) in Shandong. No significant difference of CT prevalence was found between these two studies due to overlap of 95% CI. The third cycle of the National Surveys of Sexual Attitudes and Lifestyles (Natsal-3), which was conducted in the UK in 2010–2012, indicated that the prevalence of CT infections was 1.5% (95% CI, 1.1–2.0) and 1.1% (95% CI, 0.7–1.6) for females and males 16–44 years of age, respectively [4]. In this study, prevalence of CT among males 18–44 years of age (3.0%, 95% CI, 1.8–4.3) was nearly 2 times higher than that in the UK, while difference of CT prevalence for females 18–44 years of age (2.5%, 95% CI, 1.5–3.4) was not significantly. Data from the 2011–2012 American National Health and Nutrition Examination Survey (NHANES) showed that the prevalence of CT infections among females and males 14–39 years of age was 2.0% (95% CI, 1.5–2.5) and 1.4% (95% CI, 1.1–1.8), respectively [25]. The difference of CT prevalence between males 18–39 years of age (3.2%, 95% CI, 1.8–4.6) in our study and that in the United States was marginally significant, while prevalence of CT for females 18–39 years of age (2.8%, 95% CI, 1.6–3.9) was as high as that in the US. Therefore, males in Shandong Province may suffer a higher burden of CT infection than that in the UK and US.

Our study also indicated that CT infections were more prevalent among females < 35 years of age and males < 25 years of age. Thus, these young adults need to be prioritized when implementing a CT infection control program. A previous study showed that screening for CT infections is cost-effective when the prevalence of CT infections among the female population ranged from 3.1 to 10.0% [26]. This finding indicated that the female population < 35 years of age in Shandong should be screened regularly for CT infections; however, the effectiveness of CT screening to control transmission and prevent complications of CT infection is controversial. In the UK, The National Chlamydia Screening Programme (NCSP), implemented in September 2002, offers opportunistic screening for CT infections among males and females < 25 years of age [15]; however, according to the Natsal-2 (conducted in 1999–2000) compared with Natsal-3, the prevalence of CT infections in young people 18–24 years of age was similar in females (3.1% vs. 3.2%), and males (2.9% vs. 2.6%) [4]. In 2001, the United States Preventive Services Task Force (USPSTF) recommended that clinicians routinely screen all sexually-active females ≤25 years of age, and other asymptomatic females at increased risk for CT infections [27]; however, NHANES reported a similar prevalence of CT infections in the 1999–2000 (4.1%) and 2007–2008 cycles (3.8%) among females 14–25 years of age [28]. In addition, randomized controlled trials (RCTs) also revealed contradictory evidence on the effectiveness of a CT infection screening strategy [29, 30]. The low screening efficacy on reducing the prevalence of CT infections and associated complications may be due to several factors. First, the uptake rate of CT screening is quite low in most countries that conduct screening programs. In 2017, an estimated 28% of young females and 11% of young males were tested for CT infections in England [31]. In the US, the estimated annual CT testing rate for sexually-active females 15–25 years of age was 37.9% [32]. Second, annual screening may not be frequent enough to prevent complications of CT infections. A RCT from the UK indicated that PID over 12 months was not prevented by a single CT screen and occurred in women who were negative for CT at baseline [30]. Thus, it is critical to answer questions, such as how to increase screening coverage and how often to screen through RCT or other type of studies before performing universal CT screening in Shandong, China. In our study, women 30–34 years of age had the highest prevalence of CT infections, while the highest prevalence of CT infections in males was in those 18–24 years of age. The age differentials of CT prevalence may be associated with variation of sexual desire. For males, sexual desire significantly increased after puberty and reached its peak at about 18–30 years of age [33]. For females, the sexual desire reached its peak at around 30–40 years of age [33]. Strong desire usually accompanied with frequent sexual activity, which may contribute to the high prevalence of STIs, including CT infections.

A multivariate analysis indicated that younger age at the time of first sexual intercourse is associated with a higher risk of CT infections in men. Another study showed the same conclusion among adolescents and young adults [34]. Early initiation of sexual intercourse was shown to be associated with multiple partners, more casual or commercial sex partners, and infrequent use of condoms, resulting in a higher prevalence of STIs [35]. Therefore, sex education strategies should focus on an earlier age, advice on delaying the age of first sexual intercourse, and address other issues, such as reducing the number of partners and promoting condom use [35]. The prevalence of CT infections among unmarried, divorced, or widowed females 18–49 years of age was 7.8%, which was 4 times the prevalence among married counterparts (1.8%) in this study. Data from the NHANES in 2007–2012 showed that the risk of CT infection among divorced/widowed individuals was 3 times higher than married persons [25]. Marital status is therefore a useful marker for identifying those at increased risk for a CT infection. Compared with the national CT study in 1999–2000, the difference in prevalence of CT infections among urban and rural residents is not statistically significant, which may be due to increasing proportion of migrants among the general population in China [6, 36]. The prevalence of CT was much higher for migrants than the non-migrant population [37]. Frequently, the flow of a large number of migrants may decrease the difference in STIs between urban and rural populations.

The results of this study indicate that CT infections produce a substantial economic burden in Shandong Province. The total medical costs of CT infections in Shandong Province are mainly influenced by the variation in the prevalence of CT infections rather than different methods of detection. Thus, adequate public health financial support is required to support specific CT control strategies.

Our study had several limitations. First, individuals who left their original place of residence and had lived in their current residence for ≥6 months were not completely registered by the local government and it was difficult to select all of them for sampling; however, this unregistered population could engage in more risky behaviors leading to STIs [6], thus resulting in an underestimation of the prevalence of CT and NG in our study. Second, our estimate of economic burden of CT was partially based on previous surveys. The incidence of complications after CT infection in other populations may not precisely correspond with that in Shandong Province, China. Third, the conclusions of this study might not be applicable to all provinces in China. Fourth, the statistical power of this study might be insufficient to identify potential risk factors of CT infection that were poisson distributed among general population, such as men who have sex with men (MSM) or female sex worker (FSW).

Conclusions

In conclusion, the results indicate that the prevalence of CT infections in young adults has increased rapidly since 2000. Chlamydia trachomatis is highly prevalent among females < 35 years of age and males < 25 years of age. Thus, CT control programs should focus on this population, as well as other people with identified risk factors, to reduce the prevalence and economic burden of CT infections. Further studies evaluating the effectiveness of CT control interventions through RCTs or other types of study design in China are recommended.

Abbreviations

CI:

Confidence interval

CT:

Chlamydia trachomatis

FSW:

Female sex worker

MSM:

Men who have sex with men

Natsal:

National surveys of sexual attitudes and lifestyles

NCSP:

National chlamydia screening programme

NG:

Neisseria gonorrhoeae

NHANES:

National health and nutrition examination survey

OR:

Odds ratio

PID:

Pelvic inflammatory disease

PPS:

Probability proportionate to size sampling

PSU:

Primary sampling unit

RCT:

Randomized controlled trial

RMB:

Renminbi

STI:

Sexually transmitted infection

USPSTF:

United States preventive services task force

VIF:

Variance inflation factor

WHO:

World health organization

References

  1. 1.

    Unemo M, Bradshaw CS, Hocking JS, De Vries H, Francis SC, Mabey D, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017;17:e235–79.

    Article  Google Scholar 

  2. 2.

    World Health Organization. Report on global sexually transmitted infection surveillance 2015. Retrieved March 10, 2016 from [http://apps.who.int/iris/bitstream/10665/249553/1/9789241565301-eng.pdf?ua=1]. Accessed 10 Mar 2016.

  3. 3.

    Yang S, Wu J, Ding C, Cui Y, Zhou Y, Li Y, et al. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis. 2017;17:716–25.

    Article  Google Scholar 

  4. 4.

    Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of sexual attitudes and lifestyles (Natsal). Lancet. 2013;382:1795–806.

    Article  Google Scholar 

  5. 5.

    Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004;91:2229–36.

    Article  Google Scholar 

  6. 6.

    Parish WL, Laumann EO, Cohen MS, Pan S, Zheng H, Hoffman I, et al. Population-based study of chlamydial infection in China: a hidden epidemic. JAMA. 2003;289:1265–73.

    Article  Google Scholar 

  7. 7.

    Franceschi S, Smith JS, van den Brule A, Herrero R, Arslan A, Anh PT, et al. Cervical infection with chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis. 2007;34:563–9.

    PubMed  Google Scholar 

  8. 8.

    Zeng Y, Hesketh T. The effects of China's universal two-child policy. Lancet. 2016;388:1930–8.

    Article  Google Scholar 

  9. 9.

    Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201:S134–55.

    Article  Google Scholar 

  10. 10.

    Peterman TA, Newman DR, Maddox L, Schmitt K, Shiver S. Risk for HIV following a diagnosis of syphilis, gonorrhoea or chlamydia: 328,456 women in Florida, 2000-2011. Int J STD AIDS. 2015;26:113–9.

    Article  Google Scholar 

  11. 11.

    Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1–137.

    Article  Google Scholar 

  12. 12.

    Goulet V, de Barbeyrac B, Raherison S, Prudhomme M, Semaille C, Warszawski J. Prevalence of chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infect. 2010;86:263–70.

    CAS  Article  Google Scholar 

  13. 13.

    Hocking JS, Willis J, Tabrizi S, Fairley CK, Garland SM, Hellard M. A chlamydia prevalence survey of young women living in Melbourne. Victoria Sex Health. 2006;3:235–40.

    Article  Google Scholar 

  14. 14.

    Australian Department of Health and Ageing. Second national sexually transmissible infections strategy 2010-2013. Retrieved March 10, 2016 from [http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-national-strategies-2010-sti]. Accessed 10 Mar 2016.

  15. 15.

    LaMontagne DS, Fenton KA, Randall S, Anderson S, Carter P. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect. 2004;80:335–41.

    CAS  Article  Google Scholar 

  16. 16.

    Parra-Sanchez M, Palomares JC, Bernal S, Gonzalez MT, Sivianes N, Perez L, et al. Evaluation of the cobas 4800 CT/NG test for detecting chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital swabs and urine specimens. Diagn Microbiol Infect Dis. 2012;74:338–42.

    CAS  Article  Google Scholar 

  17. 17.

    Chen S, Li J, van den Hoek A. Universal screening or prophylactic treatment for chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective? Sex Transm Dis. 2007;34:230–6.

    Article  Google Scholar 

  18. 18.

    Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health (PEACH) randomized trial. Am J Obstet Gynecol. 2002;186:929–37.

    Article  Google Scholar 

  19. 19.

    Wang QQ, Liu QZ, Xu JH. Guideline for sexually transmitted infection treatment and control in China. Shanghai: Shanghai Science and Technology Press; 2014. p. 108–9.

    Google Scholar 

  20. 20.

    Tuite AR, Jayaraman GC, Allen VG, Fisman DN. Estimation of the burden of disease and costs of genital chlamydia trachomatis infection in Canada. Sex Transm Dis. 2012;39:260–7.

    Article  Google Scholar 

  21. 21.

    Xiao Z, Mehrotra P, Zimmerman R. Sexual revolution in China: implications for Chinese women and society. AIDS Care. 2011;23:105–12.

    Article  Google Scholar 

  22. 22.

    Zhang L, Gao X, Dong Z, Tan Y, Wu Z. Premarital sexual activities among students in a university in Beijing. China Sex Transm Dis. 2002;29:212–5.

    Article  Google Scholar 

  23. 23.

    Yu XM, Guo SJ, Sun YY. Sexual behaviours and associated risks in Chinese young people: a meta-analysis. Sex Health. 2013;10:424–33.

    Article  Google Scholar 

  24. 24.

    Wong WC, Zhao Y, Wong NS, Parish WL, Miu HY, Yang LG, et al. Prevalence and risk factors of chlamydia infection in Hong Kong: a population-based geospatial household survey and testing. PLoS One. 2017;12:e172561.

    Google Scholar 

  25. 25.

    Torrone E, Papp J, Weinstock H. Prevalence of chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb Mortal Wkly Rep. 2014;63:834–8.

    PubMed  PubMed Central  Google Scholar 

  26. 26.

    Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mardh PA, et al. Cost effectiveness of screening for chlamydia trachomatis: a review of published studies. Sex Transm Infect. 2002;78:406–12.

    CAS  Article  Google Scholar 

  27. 27.

    The US. Preventive services task force. Screening for chlamydial infection: recommendations and rationale. Am J Prev Med. 2001;20:90–4.

    Google Scholar 

  28. 28.

    Datta SD, Torrone E, Kruszon-Moran D, Berman S, Johnson R, Satterwhite CL, et al. Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008. Sex Transm Dis. 2012;39:92–6.

    Article  Google Scholar 

  29. 29.

    Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;34:1362–6.

    Article  Google Scholar 

  30. 30.

    Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;c1642:340.

    Google Scholar 

  31. 31.

    Public Health England. Sexually transmitted infections and screening for Chlamydia in England, 2017. Retrieved June 6, 2018 from [https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/713962/hpr2018_AA-STIs_v5.pdf]. Accessed 6 June 2018.

  32. 32.

    Tao G, Hoover KW, Leichliter JS, Peterman TA, Kent CK. Self-reported chlamydia testing rates of sexually active women aged 15-25 years in the United States, 2006-2008. Sex Transm Dis. 2012;39:605–7.

    Article  Google Scholar 

  33. 33.

    Shui M, Hu PC. Influence factors of sex desire for women in China [article in Chinese]. Chin J Fam Plan Obstet Gyneco. 2016;2:14–6,27.

    Google Scholar 

  34. 34.

    Kaestle CE, Halpern CT, Miller WC, Ford CA. Young age at first sexual intercourse and sexually transmitted infections in adolescents and young adults. Am J Epidemiol. 2005;161:774–80.

    Article  Google Scholar 

  35. 35.

    Ma Q, Ono-Kihara M, Cong L, Xu G, Pan X, Zamani S, et al. Early initiation of sexual activity: a risk factor for sexually transmitted diseases, HIV infection, and unwanted pregnancy among university students in China. BMC Public Health. 2009;9:111.

    CAS  Article  Google Scholar 

  36. 36.

    National Bureau of Statistics of China. China statistical yearbook. Retrieved March 10, 2016 from [http://www.stats.gov.cn/tjsj/ndsj/2016/indexeh.htm]. Accessed 10 Mar 2016.

  37. 37.

    Wang W, Wei C, Buchholz ME, Martin MC, Smith BD, Huang ZJ, et al. Prevalence and risks for sexually transmitted infections among a national sample of migrants versus non-migrants in China. Int J STD AIDS. 2010;21:410–5.

    CAS  Article  Google Scholar 

Download references

Acknowledgments

The authors thank the 12 implementation partners in our survey: Station of Dermatology and Venereology in Ju county, Junan county, Qingzhou county-level city, Liaocheng municipality, Tengzhou county-level city, Qixia county-level city, Zhucheng county-level city and Linqu county, Center for Disease Control and Prevention in Chengyang District and Zoucheng county-level city, Wendeng District Hospital for Skin Disease, Zouping County Hospital of Traditional Chinese Medicine. We thank International Science Editing and Beng Tin Goh from the Royal London Hospital for editing this manuscript. We thank all men and women who participated in this study.

Funding

This study was supported by the National Key Research and Development Program of China (2016YFE0201500),the Innovation Project of Shandong Academy of Medical Sciences and the Syphilis and Other Sexually Transmitted Diseases Control Research in Shandong. The funders had no roles in the design of the study, or the collection, analysis and interpretation of data, or writing the manuscript.

Availability of data and materials

The datasets used and analyzed during the current study are not publicly available to maintain the privacy and confidentiality of the participants but are available from the corresponding author on reasonable request.

Author information

Affiliations

  1. Shandong Provincial Hospital for Skin Disease, Shandong University, Jinan, China

    Pengcheng Huai

  2. Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, 27397 Jingshi Road, Jinan, 250022, China

    Pengcheng Huai, Furong Li, Zhen Li, Lele Sun, Xi’an Fu, Qing Pan, Gongqi Yu, Zemin Chai, Tongsheng Chu, Zihao Mi, Fangfang Bao, Honglei Wang, Bingni Zhou, Chuan Wang, Yonghu Sun, Guiye Niu, Yuan Zhang, Fanghui Fu, Xiaoqiao Lang, Xiaoling Wang, Hui Zhao, Daina Liu, Hong Liu, Dianchang Liu, Jian Liu & Furen Zhang

  3. Department of Epidemiology, School of Public Health, Shandong University, Jinan, China

    Pengcheng Huai & Aiqiang Xu

  4. Shandong Provincial Key Laboratory for Dermatovenereology, Jinan, China

    Lele Sun, Xi’an Fu, Qing Pan, Gongqi Yu, Zemin Chai, Zihao Mi, Fangfang Bao, Honglei Wang, Bingni Zhou, Chuan Wang, Yonghu Sun, Guiye Niu, Yuan Zhang, Fanghui Fu, Xiaoqiao Lang, Xiaoling Wang, Hui Zhao, Daina Liu, Hong Liu & Furen Zhang

  5. Shandong Center for Disease Control and Prevention, Jinan, China

    Aiqiang Xu

Authors
  1. Pengcheng Huai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Furong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lele Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xi’an Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qing Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gongqi Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zemin Chai
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tongsheng Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Zihao Mi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Fangfang Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Honglei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Bingni Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Chuan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Yonghu Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Guiye Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Yuan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Fanghui Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Xiaoqiao Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Xiaoling Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Hui Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Daina Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Hong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Dianchang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Jian Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Aiqiang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. Furen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

FZ conceived the study. FZ, AX, JL, DL, HL and PH contributed to the design of the study. PH, FL, ZL, LS, XF, ZC, TC, HW, BZ, CW, YS, GN, YZ, FF, XL, XW, HZ and DL performed the fieldwork and data collection. LS, XF, QP, GY, ZM and FB undertook the laboratory analysis of the samples. PH conducted statistical data analysis. PH drafted the manuscript with intellectual contributions from all other authors. FZ, AX, JL, DL and HL critically revised the manuscript. All authors interpreted the data, reviewed and approved the final manuscript.

Corresponding author

Correspondence to Furen Zhang.

Ethics declarations

Ethics approval and consent to participate

This study was conducted in accordance with the ethical principles stated in the Helsinki Declaration. This study was reviews and approved by the Ethics Committee of Shandong Provincial Institute of Dermatology and Venereology (approval number: 2016–04). There were several sensitive questions related to sex in the questionnaires. Participants may refuse to answer those questions or provide untruthful information if they signed informed consent. In order to obtain true and accurate information, oral informed consent instead of written consent was obtained from each participant by interviewers before interview. This procedure was approved by the ethics committee. The name was not written on the questionnaire and the confidentiality of the data was kept properly.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional files

Additional file 1:

Sample size calculation process. (DOCX 12 kb)

Additional file 2:

Estimation process for medical cost of CT infection. (DOCX 20 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Huai, P., Li, F., Li, Z. et al. Prevalence, risk factors, and medical costs of Chlamydia trachomatis infections in Shandong Province, China: a population-based, cross-sectional study. BMC Infect Dis 18, 534 (2018). https://doi.org/10.1186/s12879-018-3432-y

Download citation

Keywords

  • Chlamydia trachomatis
  • Neisseria gonorrhea
  • Prevalence
  • Risk factor
  • Medical cost
  • General population
  • China

BMC Infectious Diseases

ISSN: 1471-2334

Contact us